Development of a genotype-matched Newcastle disease DNA vaccine candidate adjuvanted with IL-28b for the control of targeted velogenic strains of Newcastle disease virus in Africa
2025

Newcastle Disease DNA Vaccine with IL-28b Adjuvant

Sample size: 120 publication 10 minutes Evidence: moderate

Author Information

Author(s): Amoia Charlie F., Chengula Augustino A., Hakizimana Jean N., Wambura Philemon N., Munir Muhammad, Misinzo Gerald, Weger-Lucarelli James

Primary Institution: Sokoine University of Agriculture

Hypothesis

Can a genotype-matched Newcastle disease DNA vaccine adjuvanted with IL-28b improve immune responses against virulent strains of Newcastle disease virus?

Conclusion

The study found that the IL-28b adjuvanted vaccine provided better protection and immune responses compared to traditional vaccines.

Supporting Evidence

  • Chicks vaccinated with the new vaccine showed an 80% survival rate after exposure to the virus.
  • The traditional LaSota vaccine only provided a 60% survival rate.
  • IL-28b significantly enhanced immune responses in vaccinated chicks.
  • Genotype-matched vaccines are more effective than traditional vaccines against virulent strains.

Takeaway

Scientists created a new vaccine for chickens to fight a deadly bird virus, and it worked better than older vaccines.

Methodology

The study involved creating two DNA vaccines and testing their efficacy in chicks through immunization and subsequent viral challenge.

Potential Biases

Potential bias in vaccine administration and environmental factors affecting immune response.

Limitations

The study was limited to a specific region and sample size, which may not represent broader populations.

Participant Demographics

Chicks (broilers) from commercial hatcheries in Tanzania.

Statistical Information

P-Value

0.0585

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s11259-024-10590-y

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication